Who is sponsoring NCT03069235?

NCT03069235 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT03069235?

Interventions in NCT03069235: Family member / peer support, Enhanced intervention with counselor support, standard of care.

What condition does NCT03069235 study?

NCT03069235 studies HIV-infection/Aids, Breast Feeding.

Is NCT03069235 still recruiting?

NCT03069235 is currently completed. Last updated 3 March 2017.

Last reviewed 2017-03-03 · How we verify

NCT03069235: EBF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program

Completed NA Last updated 3 March 2017

What this trial tests

NA trial testing Family member / peer support in HIV-infection/Aids in 218 participants. Completed in 30 November 2013.

Timeline

8 February 2012

Primary endpoint
30 November 2013

30 November 2013

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	218
Start date	8 February 2012
Primary completion	30 November 2013
Estimated completion	30 November 2013

Drugs / interventions tested

Family member / peer support
Enhanced intervention with counselor support
standard of care

Conditions studied

HIV-infection/Aids — all drugs for HIV-infection/Aids →
Breast Feeding — all drugs for Breast Feeding →

Sponsor

Johns Hopkins University

Who can join

Adults 18 to 50, female only, with HIV-infection/Aids or Breast Feeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates strategies aimed at promoting exclusive breast feeding for 6 months followed by continued breastfeeding for the next 6 months with introduction of complementary foods among HIV infected women in a resource limited setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03069235 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 3 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03069235.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing